Sofosbuvir for Previously Untreated Chronic Hepatitis C InfectionEric Lawitz, Edward Gane, K. Rajender Reddy et al.|New England Journal of Medicine|2013Cited by 1.8k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M. Younossi, Victor Ankoma‐Sey, Vlad Ratziu et al.|The Lancet|2019Cited by 1.2k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without CirrhosisKris V. Kowdley, Michael Fried, Stuart C. Gordon et al.|New England Journal of Medicine|2014Cited by 1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment OptionsIra M. Jacobson, David R. Nelson, Stuart C. Gordon et al.|New England Journal of Medicine|2013Cited by 1.1k
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III studyDavid R. Nelson, James N. Cooper, Jacob Lalezari et al.|Hepatology|2015Cited by 689